Related Experiment Video
Updated: Apr 3, 2026

07:23
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
3.3K
Artificial intelligence in retinal vein occlusion: Current applications, challenges, and future directions
Sónia Torres-Costa1, Sofia Machado2, Guilherme Barbosa3
1Ophthalmology Department, Unidade de Saúde Local de São João, Porto, Portugal; Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.
Survey of Ophthalmology
|April 1, 2026
Summary
Artificial intelligence (AI) shows promise for analyzing retinal images to detect and manage retinal vein occlusion (RVO). However, challenges like data limitations and validation hinder widespread clinical use of these AI tools.
Area of Science:
- Ophthalmology
- Medical Imaging
- Artificial Intelligence
Background:
- Retinal vein occlusion (RVO) is a major cause of vision loss globally.
- Early detection and personalized management of RVO are crucial.
- Current diagnostic methods require improvement for objective risk stratification.
Purpose of the Study:
- To review current artificial intelligence (AI) applications in retinal vein occlusion (RVO).
- To focus on AI for disease detection, classification, ischemia assessment, and treatment support.
- To evaluate the clinical relevance and translational maturity of AI in RVO.
Main Methods:
- Systematic review and synthesis of AI applications in RVO research.
- Analysis of studies using color fundus photography, OCT, OCT angiography, and fluorescein angiography.
- Evaluation of AI model performance, methodological trends, and clinical relevance.
Main Results:
- AI, particularly deep learning, demonstrates high performance in detecting and classifying RVO from retinal images in experimental settings.
- Multimodal imaging and lesion-centric approaches enhance AI model accuracy.
- Most current AI evidence is from retrospective studies with limited validation.
Conclusions:
- AI holds significant potential for improving RVO diagnosis and management.
- Barriers to clinical adoption include data limitations, lack of prospective validation, and standardization issues.
- Future AI development should focus on multicenter validation, interpretability, and tools that aid clinical decision-making.

